NEJMJClubDrug-Induced Subacute Cutaneous Lupus Erythematosus.New England Journal of Medicine · 20 Aug 2026 · Case ReportsDrug-Induced Subacute Cutaneous Lupus Erythematosus.Ipenburg, SangersAbstract ↗AI briefThe abstract is read at the publisher; the brief is JClub's.The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.Read the brief in JClub →Related in JClubNEJMJClubEfficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus.New England Journal of Medicine · 16 July 2026 · Randomized Controlled TrialObinutuzumab significantly improves disease activity in adults with active systemic lupus erythematosus, achieving a 23.1 percentage point higher response rate than placebo at week 52.25 citesOpenShareCopy linkPost on XPost on BlueskyShare on LinkedInhttps://jclub.com.au/a/41789864Open in JClub
NEJMJClubEfficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus.New England Journal of Medicine · 16 July 2026 · Randomized Controlled TrialObinutuzumab significantly improves disease activity in adults with active systemic lupus erythematosus, achieving a 23.1 percentage point higher response rate than placebo at week 52.25 citesOpenShareCopy linkPost on XPost on BlueskyShare on LinkedInhttps://jclub.com.au/a/41789864Open in JClub